Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COX17 pseudogene 1 (COX17P1) is a non-functional genetic element located on chromosome 13, sharing sequence similarity with the functional COX17 gene, which encodes a mitochondrial copper chaperone[2][1]. The pseudogene is characterized by nucleotide changes—including alterations in the copper binding domain—that prevent it from producing active protein. Pseudogenes such as COX17P1 have no known roles in copper trafficking, mitochondrial function, or disease, and are not considered therapeutic targets. Only the functional COX17 gene has established involvement in mitochondrial copper transport and assembly of complex IV of the respiratory chain, but COX17P1 itself is genomically silent and not biologically relevant as a drug target[2][1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COX17 pseudogene 1 (COX17P1).